NIH COVID-19 Training and Fellowship Updates

This webpage provides guidance about no-cost extensions, with or without funds, eligibility extensions, and COVID related FAQs and notices for the NIH Pathway to Independence Awards (K99/R00), Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowships, and other funding mechanisms.

Eligibility Extensions for New K99/R00 Applicants

  • Under normal circumstances, individuals must have no more than four years of postdoctoral research experience to be eligible to apply for a K99/R00 Pathway to Independence award. Due to disruptions caused by the COVID-19 pandemic, NIH will be providing up to a two-receipt cycle extension (roughly eight additional months) of eligibility for prospective applicants meeting the requirements for submission of a K99/R00 application from the time period covered by the June/July 2020 due dates through the February/March 2021 due dates, as described in NOT-OD-20-158

Active Grant Extensions – K99/R00

  • No-cost Extensions for K99/R00 Awards
    As per NOT-OD-16-092, a no-cost extension may be allowed should additional time be needed to complete the goals of the K99 phase. No-cost extensions for K99 awards, however, are not automatic and require prior approval by the NIH. All terms and conditions of the K99/R00 award (including minimum effort requirements) remain in effect when the grant is in a no-cost extension. In requesting a no-cost extension, K99 awardees wishing to continue to seek a tenure-track or equivalent position should submit a plan for continued career development and a timely transition to an independent position.
  • COVID-19 Pandemic Effects on K99/R00 Funding
    NIH allows for flexibilities to applicants and recipients of federal financial assistance who have been affected by the COVID-19 pandemic as described in NOT-OD-20-086.

    K99/R00 recipients may extend awards affected by the COVID-19 pandemic through a notification to the funding Institute or Center (IC). For awards where such an extension impacts research progress, the IC may consider providing support to help address any impact on the NIH-funded research. NIH is providing maximum flexibility and will accept these requests from recipients affected by COVID-19. Individuals and mentors should contact the funding IC in writing to provide details on the delays related to COVID-19. Extensions may be provided and administrative supplements are at the discretion of the funding IC.

    For more information about K99 extensions related to the pandemic, grantees are encouraged to visit the NIH Training & Education FAQ webpage. 

Active Grant Extensions – NRSA and/or Fellowship Awards

  • For fellowship recipients, ICs may approve exceptions to the limits on aggregate Kirschstein-NRSA support (see Grants Policy Statement 11.2.6) for recipients affected by the COVID-19 pandemic. As detailed in the Grants Policy Statement, the awarding IC may approve these requests, which must be submitted in writing by the Authorized Organization Representative of the sponsoring institution. The request must outline the effects of COVID-19 and must specify the amount of additional support for which approval is sought.
  • Recipients of NRSA fellowship awards may submit extension requests to the funding IC for consideration when the effects of COVID-19 have altered the planned course of the research training. Extension requests must include a description of how COVID-19 affected the fellowship award, and clearly outline how much additional time is needed. All such requests must be signed by the fellow, the Authorized Organization Representative, and the fellowship sponsor.

For More Information

NIH Guide Notices

Title Date Description
NOT-OD-20-158 8/11/2020 Temporary two cycle eligibility extension for K99/R00 applicants
NOT-OD-20-091 3/26/2020 UPDATE: NIH Late Application Policy Due to Public Health Emergency for United States for 2019 Novel Coronavirus (COVID-19)
NOT-OD-20-088 3/17/2020 Flexibilities for Assured Institutions for Activities of Institutional Animal Care and Use Committees (IACUCs) Due to COVID-19
NOT-OD-20-087 3/16/2020 Guidance for NIH-funded Clinical Trials and Human Subjects Studies Affected by COVID-19
NOT-OD-20-086 3/12/2020 Flexibilities Available to Applicants and Recipients of Federal Financial Assistance Affected by COVID-19
NOT-OD-20-083 3/10/2020 General Frequently Asked Questions (FAQs) - Proposal Submission and Award Management Related to COVID-19
NOT-OD-20-082 3/9/2020 NIH Late Application Policy Due to Public Health Emergency for United States for 2019 Novel Coronavirus (COVID-19)